Maternal Efficacy and Safety Outcomes in a Randomized, Controlled Trial Comparing Insulin Detemir With NPH Insulin in 310 Pregnant Women With Type 1 Diabetes

2012215 citationsJournal Articlehybrid Open Access

Authors

Treatment with IDet resulted in lower FPG and noninferior A1C in late pregnancy compared with NPH insulin. Rates of hypoglycemia were comparable.

Good health and well-being

Published in: Diabetes Care

Volume 35, Issue 10, pp. 2012-2017

Field-Weighted Citation Impact: 15.39